Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.56 |
| ▸ | MEN1 | O00255 | 5/20 | 0.56 |
| ▸ | PKM | P14618 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 8/20 | 0.54 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1923694 | 0.85 | ALDH1A1 (0.61) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL1923000 | 0.83 | ALDH1A1 (0.73) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL1923376 | 0.83 | ALDH1A1 (0.58) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL1923385 | 0.83 | ALDH1A1 (0.56) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL1923366 | 0.82 | ALDH1A1 (0.72) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL15922228 | 0.81 | ALDH1A1 (0.55) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL1923685 | 0.80 | ALDH1A1 (0.56) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL1923327 | 0.80 | ALDH1A1 (0.55) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL1923358 | 0.79 | ALDH1A1 (0.61) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL12156722 | 0.79 | NPC1 (0.58) | ALDH1A1KMT2AMEN1PKMMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8049037-B2 | Sphingosine-1-phosphate (S1P) receptor antagonists and methods for use thereof | ALLERGAN, INC. (US) | 2011-11-01 | — | — | US | disclosed |
| US-8049037-B2 | Sphingosine-1-phosphate (S1P) receptor antagonists and methods for use thereof | ALLERGAN, INC. (US) | 2011-11-01 | — | — | US | disclosed |
| US-8049037-B2 | Sphingosine-1-phosphate (S1P) receptor antagonists and methods for use thereof | ALLERGAN, INC. (US) | 2011-11-01 | — | — | US | disclosed |
| EP-2328863-A1 | SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ANTAGONISTS AND METHODS FOR USE THEREOF | Allergan, Inc. (US) | 2011-06-08 | — | — | EP | disclosed |
| WO-2010019646-A1 | SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ANTAGONISTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2010-02-18 | — | — | WO | disclosed |
| US-20100041715-A1 | SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ANTAGONISTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2010-02-18 | — | — | US | disclosed |
| US-20100041715-A1 | SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ANTAGONISTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2010-02-18 | — | — | US | disclosed |
| US-20100041715-A1 | SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ANTAGONISTS AND METHODS FOR USE THEREOF | ALLERGAN, INC. (US) | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041715-A1 | SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ANTAGONISTS AND METHODS FOR USE THEREOF | S1PR1, S1PR2, S1PR3 | ALDH1A1 2830/4885KMT2A 2540/4885MEN1 2283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.